Predictive value of immune cell counts and neutrophil-to-lymphocyte ratio for 28-day mortality in patients with sepsis caused by intra-abdominal infection

Abstract

Background: The current study aimed to evaluate the value of immune cell counts and neutrophil-to-lymphocyte ratio (NLR) when attempting to predict 28-day mortality. Methods: We conducted an observational retrospective study that included consecutive septic patients. Severity scores on the first day and peripheral circulating immune cell counts (at day 1, day 3, day 5 and day 7 of admission) were collected during each patient’s emergency intensive care unit stay. We assessed the associations of peripheral circulating immune cell counts and NLR with the severity of illness. The relationships between 28-day mortality and peripheral circulating immune cell counts and NLR with were evaluated using Cox proportional cause-specific hazards models. Results: A total of 216 patients diagnosed with sepsis caused by IAI were enrolled. The lymphocyte counts (days 1, 3, 5 and 7) and monocyte counts (days 3, 5 and 7) were significantly lower in non-survivors (n = 72) than survivors (n = 144). The NLR values at each time point were significantly higher in non-survivors. The day 1 lymphocyte counts, as well as the monocyte counts, were significantly lower in the highest-scoring group, when stratified by the Acute Physiology and Chronic Health Evaluation II and Sequential Organ Failure Assessment scores, than in the other groups (p < 0.05). The day 1 NLR was significantly higher in the highest-scoring group than in the other groups (p < 0.05). The day 5 and day 7 lymphocyte counts, day 3 and day 7 monocyte counts and day 7 NLR were significant predictors of 28-day mortality in the Cox proportional hazards models (day 5 lymphocyte count: hazard ratio, 0.123 (95% CI, 0.055–0.279), p < 0.001; day 7 lymphocyte count: hazard ratio, 0.115 (95% CI, 0.052–0.254), p < 0.001; day 3 monocyte count: hazard ratio, 0.067 (95% CI, 0.005–0.861), p = 0.038; day 7 monocyte count: hazard ratio, 0.015 (95% CI, 0.001–0.158), p < 0.001; day 7 NLR: hazard ratio, 0.773 (95% CI, 0.659–0.905), p = 0.001). Conclusions: The results showed that circulating lymphocytes and monocytes were dramatically decreased within 7 days in non-survivors following sepsis from an IAI. Lymphocyte counts, monocyte counts and NLR appeared to be associated with the severity of illness, and they may serve as independent predictors of 28-day mortality in septic patients with IAIs.

Keywords

Lymphocyte counts / Monocyte counts / Predictive value / Mortality / Sepsis / Intra-abdominal infection

References

[1] Denning NL, Aziz M, Gurien SD, Wang P. DAMPs and NETs in sepsis. Front Immunol. 2019. https://doi.org/10.3389/fimmu.2019.02536.

[2] Razazi K, Boissier F, Surenaud M, Bedet A, Seemann A, Carteaux G, et al. A multiplex analysis of sepsis mediators during human septic shock: a preliminary study on myocardial depression and organ failures. Ann Intensive Care. 2019; 9: 64.

[3] Hoffman M, Kyriazis ID, Lucchese AM, de Lucia C, Piedepalumbo M, Bauer M, et al. Myocardial strain and cardiac output are preferable measurements for cardiac dysfunction and can predict mortality in septic mice. J Am Heart Assoc. 2019. https://doi.org/10.1161/JAHA.119.012260.

[4] Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of hospital-treated sepsis: current estimates and limitations. Am J Respir Crit Care Med. 2016; 193: 259-72.

[5] Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006; 34: 344-53.

[6] Lilly EA, Ikeh M, Nash EE, Fidel PL Jr, Noverr MC. Immune protection against lethal fungal-bacterial intra-abdominal infections. mBio. 2018. https://doi.org/10.1128/mBio.01472-17.

[7] Mureşan MG, Balmoş IA, Badea I, Santini A. Abdominal sepsis: an update. J Crit Care Med (Targu Mures). 2018; 4: 120-5.

[8] Volakli E, Spies C, Michalopoulos A, Groeneveld AB, Sakr Y, Vincent JL. Infections of respiratory or abdominal origin in ICU patients: what are the differences? Crit Care. 2010. https://doi.org/10.1186/cc8909.

[9] van de Groep K, Verhoeff TL, Verboom DM, Bos LD, Schultz MJ, Bonten MJM, et al. Epidemiology and outcomes of source control procedures in critically ill patients with intra-abdominal infection. J Crit Care. 2019; 52: 258-64.

[10] Sartelli M, Catena F, Ansaloni L, Leppaniemi A, Taviloglu K, van Goor H, et al. Complicated intra-abdominal infections in Europe: a comprehensive review of the CIAO study. World J Emerg Surg. 2012. https://doi.org/10.1186/1749-7922-7-36.

[11] Rattan R, Allen CJ, Sawyer RG, Askari R, Banton KL, Claridge JA, et al. Patients with complicated intra-abdominal infection presenting with Sepsis do not require longer duration of antimicrobial therapy. J Am Coll Surg. 2016; 222: 440-6.

[12] Cao C, Yu M, Chai Y. Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis. Cell Death Dis. 2019. https://doi.org/10.1038/s41419-019-2015-1.

[13] Hajsadeghi S, Pakbaz M, Aziz Ahari A, Kalantari S. Co-infection with bacterial and fungal endocarditis at scar tissue in an immunocompromised patient. J Cardiol Cases. 2018; 19: 117-20.

[14] Kaushik A, Kest H. The role of antifungals in Pediatric critical care invasive fungal infections. Critical Care Research Practice. 2018. https://doi.org/10.1155/2018/8469585.

[15] Torgersen C, Moser P, Luckner G, Mayr V, Jochberger S, Hasibeder WR, et al. Macroscoic postmortem findings in 235 surgical intensive care patients with f sepsis. Anesth Analg. 2009; 108: 1841-7.

[16] Rimmelé T, Payen D, Cantaluppi V, Marshall J, Gomez H, Gomez A, et al. Immune cell phenotype and function in sepsis. Shock. 2016; 45: 282-91.

[17] Grailer JJ, Kalbitz M, Zetoune FS, Ward PA. Persistent neutrophil dysfunction and suppression of acute lung injury in mice following cecal ligation and puncture sepsis. J Innate Immun. 2014; 6: 695-705.

[18] Otto GP, Sossdorf M, Claus RA, Rödel J, Menge K, Reinhart K, et al. The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit Care. 2011. https://doi.org/10.1186/cc10332.

[19] Delano MJ, Ward PA. The immune system’s role in sepsis progression, resolution, and long-term outcome. Immunol Rev. 2016; 274: 330-53.

[20] Ni J, Wang H, Li Y, Shu Y, Liu Y. Neutrophil to lymphocyte ratio (NLR) as a prognostic marker for in-hospital mortality of patients with sepsis: a secondary analysis based on a single-center, retrospective, cohort study. Medicine (Baltimore). 2019. https://doi.org/10.1097/MD.0000000000018029.

[21] Azab B, Bhatt VR, Phookan J, Murukutla S, Kohn N, Terjanian T, et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short-and long-term mortality in breast cancer patients. Ann Surg Oncol. 2012; 19: 217-24.

[22] Petrova MP, Eneva MI, Arabadjiev JI, Conev NV, Dimitrova EG, Koynov KD, et al. Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer. Biosci Trends. 2020; 14: 48-55.

[23] Jiang L, Fang J, Ding J. High systemic immune-inflammation index predicts poor survival in patients with human epidermal growth factor Receptor-2 positive breast cancer receiving adjuvant Trastuzumab. Cancer Manag Res. 2020; 12: 475-84.

[24] Meshaal MS, Nagi A, Eldamaty A, Elnaggar W, Gaber M, Rizk H. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as independent predictors of outcome in infective endocarditis (IE). Egypt Heart J. 2019. https://doi.org/10.1186/s43044-019-0014-2.

[25] Giede-Jeppe A, Reichl J, Sprügel MI, Lücking H, Hoelter P, Eyüpoglu IY, et al. Neutrophil-to-lymphocyte ratio as an independent predictor for unfavorable functional outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg. 2019; 132: 100-7.

[26] Sarı R, Karakurt Z, Ay M, Çelik ME, Yalaz Tekan Ü, Çiyiltepe F, et al. Neutrophil to lymphocyte ratio as a predictor of treatment response and mortality in septic shock patients in the intensive care unit. Turk J Med Sci. 2019; 49: 1336- 49.

[27] Liu Y, Zheng J, Zhang D, Jing L. Neutrophil-lymphocyte ratio and plasma lactate predict 28-day mortality in patients with sepsis. J Clin Lab Anal. 2019. https://doi.org/10.1002/jcla.22942.

[28] Riché F, Gayat E, Barthélémy R, le Dorze M, Matéo J, Payen D. Reversal of neutrophil-to-lymphocyte count ratio in early versus late death from septic shock. Crit Care. 2015. https://doi.org/10.1186/s13054-015-1144-x.

[29] Huang Z, Fu Z, Huang W, Huang K. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: a meta-analysis. Am J Emerg Med. 2020; 38: 641-7.

[30] Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315: 801-10.

[31] Xu Z, Cheng B, Fu S, Liu X, Xie G, Li Z, et al. Coagulative biomarkers on admission to the ICU predict acute kidney injury and mortality in patients with septic shock caused by intra-abdominal infection. Infect Drug Resist. 2019; 12: 2755-64.

[32] Yoon YK, Kim J, Moon C, Lee MS, Hur J, Lee H, et al. Antimicrobial susceptibility of microorganisms isolated from patients with intraabdominal infection in Korea: a Multicenter study. J Korean Med Sci. 2019. https://doi.org/10.3346/jkms.2019.34.e309.

[33] DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44: 837-45.

[34] Yin Y, Tao J, Duan Z, Chen F. Dong L. APACHE II scoring used in evaluating the prognosis of patients with emergency critical value of research. Contemporary. Medicine. 2019; 25: 85-7.

[35] Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med. 1998; 26: 1793-800.

[36] Walker AMN, Drozd M, Hall M, Patel PA, Paton M, Lowry J, et al. Prevalence and predictors of sepsis death in patients with chronic heart failure and reduced left ventricular ejection fraction. J Am Heart Assoc. 2018. https://doi.org/10.1161/JAHA.118.009684.

[37] Huet O, Chin-Dusting JP. Septic shock: desperately seeking treatment. Clin Sci (Lond). 2014; 126: 31-9.

[38] Dünser MW, Takala J, Ulmer H, Mayr VD, Luckner G, Jochberger S, et al. Arterial blood pressure during early sepsis and outcome. Intensive Care Med. 2009; 35: 1225-33.

[39] Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017; 43: 304-77.

[40] Chirico G, Cortinovis S, Fonte C, Giudici G. Bacterial sepsis. J Chemother. 2007; 19: 28-30.

[41] Bradford R, O’Loughlin K, Munro A, Jani BR, Singham S, Cansick J. Bacterial-fungal interactions including quorum sensing, between 2 opportunistic pathogens, resulting in post-traumatic sepsis in a child presenting with a closed femoral fracture. Pediatr Infect Dis J. 2016; 35: 1360-2.

[42] Xue M, Zhang S, Xie J, Zhang X, Liu F, Huang Y, et al. Differential expression of genes associated with T lymphocytes function in septic patients with hypoxemia challenge. Ann Transl Med. 2019. https://doi.org/10.21037/atm.2019.12.63.

[43] Drewry AM, Samra N, Skrupky LP, Fuller BM, Compton SM, Hotchkiss RS. Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock. 2014; 42: 383-91.

[44] Monserrat J, de Pablo R, Diaz-Martín D, Rodríguez-Zapata M, de la Hera A, Prieto A, et al. Early alterations of B cells in patients with septic shock. Crit Care. 2013. https://doi.org/10.1186/cc12750.

[45] Inoue S, Suzuki-Utsunomiya K, Okada Y, Taira T, Iida Y, Miura N, et al. Reduction of immunocompetent T cells followed by prolonged lymphopenia in severe sepsis in the elderly. Crit Care Med. 2013; 41: 810-9.

[46] Patil NK, Bohannon JK, Sherwood ER. Immunotherapy: a promising approach to reverse sepsis-induced immunosuppression. Pharmacol Res. 2016; 111: 688-702.

[47] Chung H, Lee JH, Jo YH, Hwang JE, Kim J. Circulating monocyte counts and its impact on outcomes in patients with severe sepsis including septic shock. Shock. 2019; 51: 423-9.

[48] Gainaru G, Papadopoulos A, Tsangaris I, Lada M, Giamarellos-Bourboulis EJ, Pistiki A. Increases in inflammatory and CD14^dim/CD16^pos/CD45^pos patrolling monocytes in sepsis: correlation with final outcome. Crit Care. 2018. https://doi.org/10.1186/s13054-018-1977-1.

[49] Patel AA, Zhang Y, Fullerton JN, Boelen L, Rongvaux A, Maini AA, et al. The fate and lifespan of human monocyte subsets in steady state and systemic inflammation. J Exp Med. 2017; 214: 1913-23.

[50] Ceccato A, Panagiotarakou M, Ranzani OT, Martin-Fernandez M, Almansa-Mora R, Gabarrus A, et al. Lymphocytopenia as a predictor of mortality in patients with ICU-acquired pneumonia. J Clin Med. 2019. https://doi.org/10.3390/jcm8060843.

[51] Conlledo R, Rodríguez Á, Godoy J, Merino C, Martínez F. Total globulins and lymphocyte count as markers of mortality in sepsis and septic shock. Rev Chilena Infectol. 2012; 29: 192-9.

[52] Cheng YC, Pei YX, Huang MH, Liu SS, Huang XQ, Tang W. Prognostic value of neutrophil-lymphocyte ratio on septic children. Shandong Medical Journal. 2016; 56: 48-50.